nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.167	0.195	CbGbCtD
Gadoxetate—ABCC2—Sulfasalazine—ankylosing spondylitis	0.147	0.171	CbGbCtD
Gadoxetate—ABCC3—Methotrexate—ankylosing spondylitis	0.13	0.151	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—ankylosing spondylitis	0.115	0.134	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—ankylosing spondylitis	0.099	0.116	CbGbCtD
Gadoxetate—ABCC2—Dexamethasone—ankylosing spondylitis	0.0733	0.0855	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—ankylosing spondylitis	0.067	0.0782	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—ankylosing spondylitis	0.0589	0.0687	CbGbCtD
Gadoxetate—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000345	0.0024	CcSEcCtD
Gadoxetate—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000343	0.00239	CcSEcCtD
Gadoxetate—Malaise—Prednisolone—ankylosing spondylitis	0.000339	0.00236	CcSEcCtD
Gadoxetate—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000339	0.00236	CcSEcCtD
Gadoxetate—Vertigo—Prednisolone—ankylosing spondylitis	0.000338	0.00235	CcSEcCtD
Gadoxetate—Syncope—Prednisolone—ankylosing spondylitis	0.000337	0.00235	CcSEcCtD
Gadoxetate—Back pain—Triamcinolone—ankylosing spondylitis	0.000334	0.00233	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00033	0.0023	CcSEcCtD
Gadoxetate—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000327	0.00228	CcSEcCtD
Gadoxetate—Angiopathy—Betamethasone—ankylosing spondylitis	0.000327	0.00228	CcSEcCtD
Gadoxetate—Convulsion—Prednisolone—ankylosing spondylitis	0.000326	0.00227	CcSEcCtD
Gadoxetate—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000322	0.00224	CcSEcCtD
Gadoxetate—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000322	0.00224	CcSEcCtD
Gadoxetate—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000321	0.00224	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00032	0.00223	CcSEcCtD
Gadoxetate—Discomfort—Prednisolone—ankylosing spondylitis	0.000316	0.0022	CcSEcCtD
Gadoxetate—Malaise—Triamcinolone—ankylosing spondylitis	0.000312	0.00217	CcSEcCtD
Gadoxetate—Malaise—Methylprednisolone—ankylosing spondylitis	0.000311	0.00217	CcSEcCtD
Gadoxetate—Vertigo—Triamcinolone—ankylosing spondylitis	0.000311	0.00217	CcSEcCtD
Gadoxetate—Syncope—Triamcinolone—ankylosing spondylitis	0.00031	0.00216	CcSEcCtD
Gadoxetate—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00031	0.00216	CcSEcCtD
Gadoxetate—Syncope—Methylprednisolone—ankylosing spondylitis	0.000309	0.00216	CcSEcCtD
Gadoxetate—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000308	0.00215	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000307	0.00214	CcSEcCtD
Gadoxetate—Oedema—Prednisolone—ankylosing spondylitis	0.000307	0.00214	CcSEcCtD
Gadoxetate—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000304	0.00212	CcSEcCtD
Gadoxetate—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000303	0.00211	CcSEcCtD
Gadoxetate—Shock—Prednisolone—ankylosing spondylitis	0.000302	0.0021	CcSEcCtD
Gadoxetate—Cough—Triamcinolone—ankylosing spondylitis	0.000302	0.0021	CcSEcCtD
Gadoxetate—Convulsion—Triamcinolone—ankylosing spondylitis	0.0003	0.00209	CcSEcCtD
Gadoxetate—Tachycardia—Prednisolone—ankylosing spondylitis	0.000299	0.00209	CcSEcCtD
Gadoxetate—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000299	0.00208	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000297	0.00207	CcSEcCtD
Gadoxetate—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000293	0.00204	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000292	0.00203	CcSEcCtD
Gadoxetate—Flushing—Prednisone—ankylosing spondylitis	0.000291	0.00203	CcSEcCtD
Gadoxetate—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000291	0.00203	CcSEcCtD
Gadoxetate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000291	0.00203	CcSEcCtD
Gadoxetate—Discomfort—Triamcinolone—ankylosing spondylitis	0.000291	0.00203	CcSEcCtD
Gadoxetate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00029	0.00202	CcSEcCtD
Gadoxetate—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000288	0.00201	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—ankylosing spondylitis	0.000287	0.002	CcSEcCtD
Gadoxetate—Angiopathy—Prednisone—ankylosing spondylitis	0.000285	0.00198	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000284	0.00198	CcSEcCtD
Gadoxetate—Immune system disorder—Prednisone—ankylosing spondylitis	0.000283	0.00198	CcSEcCtD
Gadoxetate—Malaise—Betamethasone—ankylosing spondylitis	0.000283	0.00197	CcSEcCtD
Gadoxetate—Malaise—Dexamethasone—ankylosing spondylitis	0.000283	0.00197	CcSEcCtD
Gadoxetate—Oedema—Triamcinolone—ankylosing spondylitis	0.000282	0.00197	CcSEcCtD
Gadoxetate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000282	0.00197	CcSEcCtD
Gadoxetate—Vertigo—Betamethasone—ankylosing spondylitis	0.000282	0.00196	CcSEcCtD
Gadoxetate—Vertigo—Dexamethasone—ankylosing spondylitis	0.000282	0.00196	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000281	0.00196	CcSEcCtD
Gadoxetate—Syncope—Betamethasone—ankylosing spondylitis	0.000281	0.00196	CcSEcCtD
Gadoxetate—Syncope—Dexamethasone—ankylosing spondylitis	0.000281	0.00196	CcSEcCtD
Gadoxetate—Arrhythmia—Prednisone—ankylosing spondylitis	0.00028	0.00195	CcSEcCtD
Gadoxetate—Infection—Triamcinolone—ankylosing spondylitis	0.00028	0.00195	CcSEcCtD
Gadoxetate—Infection—Methylprednisolone—ankylosing spondylitis	0.00028	0.00195	CcSEcCtD
Gadoxetate—Shock—Triamcinolone—ankylosing spondylitis	0.000278	0.00194	CcSEcCtD
Gadoxetate—Shock—Methylprednisolone—ankylosing spondylitis	0.000277	0.00193	CcSEcCtD
Gadoxetate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000276	0.00192	CcSEcCtD
Gadoxetate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000276	0.00192	CcSEcCtD
Gadoxetate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000276	0.00192	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000275	0.00192	CcSEcCtD
Gadoxetate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000275	0.00192	CcSEcCtD
Gadoxetate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000275	0.00192	CcSEcCtD
Gadoxetate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000273	0.00191	CcSEcCtD
Gadoxetate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000273	0.0019	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000272	0.0019	CcSEcCtD
Gadoxetate—Convulsion—Dexamethasone—ankylosing spondylitis	0.000272	0.00189	CcSEcCtD
Gadoxetate—Convulsion—Betamethasone—ankylosing spondylitis	0.000272	0.00189	CcSEcCtD
Gadoxetate—Anxiety—Dexamethasone—ankylosing spondylitis	0.000266	0.00186	CcSEcCtD
Gadoxetate—Anxiety—Betamethasone—ankylosing spondylitis	0.000266	0.00186	CcSEcCtD
Gadoxetate—Discomfort—Dexamethasone—ankylosing spondylitis	0.000264	0.00184	CcSEcCtD
Gadoxetate—Discomfort—Betamethasone—ankylosing spondylitis	0.000264	0.00184	CcSEcCtD
Gadoxetate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000263	0.00183	CcSEcCtD
Gadoxetate—Vision blurred—Prednisone—ankylosing spondylitis	0.000257	0.00179	CcSEcCtD
Gadoxetate—Oedema—Dexamethasone—ankylosing spondylitis	0.000256	0.00178	CcSEcCtD
Gadoxetate—Oedema—Betamethasone—ankylosing spondylitis	0.000256	0.00178	CcSEcCtD
Gadoxetate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000256	0.00178	CcSEcCtD
Gadoxetate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000256	0.00178	CcSEcCtD
Gadoxetate—Infection—Dexamethasone—ankylosing spondylitis	0.000254	0.00177	CcSEcCtD
Gadoxetate—Infection—Betamethasone—ankylosing spondylitis	0.000254	0.00177	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000253	0.00177	CcSEcCtD
Gadoxetate—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000253	0.00177	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000253	0.00176	CcSEcCtD
Gadoxetate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000253	0.00176	CcSEcCtD
Gadoxetate—Shock—Betamethasone—ankylosing spondylitis	0.000252	0.00176	CcSEcCtD
Gadoxetate—Shock—Dexamethasone—ankylosing spondylitis	0.000252	0.00176	CcSEcCtD
Gadoxetate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000252	0.00175	CcSEcCtD
Gadoxetate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000251	0.00175	CcSEcCtD
Gadoxetate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000251	0.00175	CcSEcCtD
Gadoxetate—Agitation—Prednisone—ankylosing spondylitis	0.000251	0.00175	CcSEcCtD
Gadoxetate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00025	0.00174	CcSEcCtD
Gadoxetate—Tachycardia—Betamethasone—ankylosing spondylitis	0.00025	0.00174	CcSEcCtD
Gadoxetate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000247	0.00173	CcSEcCtD
Gadoxetate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000247	0.00173	CcSEcCtD
Gadoxetate—Malaise—Prednisone—ankylosing spondylitis	0.000246	0.00172	CcSEcCtD
Gadoxetate—Vertigo—Prednisone—ankylosing spondylitis	0.000245	0.00171	CcSEcCtD
Gadoxetate—Syncope—Prednisone—ankylosing spondylitis	0.000245	0.00171	CcSEcCtD
Gadoxetate—Anorexia—Betamethasone—ankylosing spondylitis	0.000244	0.0017	CcSEcCtD
Gadoxetate—Anorexia—Dexamethasone—ankylosing spondylitis	0.000244	0.0017	CcSEcCtD
Gadoxetate—Urticaria—Prednisolone—ankylosing spondylitis	0.000244	0.0017	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000243	0.0017	CcSEcCtD
Gadoxetate—Fatigue—Triamcinolone—ankylosing spondylitis	0.000243	0.0017	CcSEcCtD
Gadoxetate—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000243	0.00169	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00024	0.00167	CcSEcCtD
Gadoxetate—Hypotension—Dexamethasone—ankylosing spondylitis	0.000239	0.00167	CcSEcCtD
Gadoxetate—Hypotension—Betamethasone—ankylosing spondylitis	0.000239	0.00167	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—ankylosing spondylitis	0.000238	0.00166	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000237	0.00165	CcSEcCtD
Gadoxetate—Convulsion—Prednisone—ankylosing spondylitis	0.000237	0.00165	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000236	0.00165	CcSEcCtD
Gadoxetate—Chills—Methotrexate—ankylosing spondylitis	0.000235	0.00164	CcSEcCtD
Gadoxetate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000232	0.00162	CcSEcCtD
Gadoxetate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000232	0.00162	CcSEcCtD
Gadoxetate—Anxiety—Prednisone—ankylosing spondylitis	0.000232	0.00162	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000231	0.00161	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00023	0.0016	CcSEcCtD
Gadoxetate—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00023	0.0016	CcSEcCtD
Gadoxetate—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00023	0.0016	CcSEcCtD
Gadoxetate—Discomfort—Prednisone—ankylosing spondylitis	0.00023	0.0016	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000226	0.00158	CcSEcCtD
Gadoxetate—Urticaria—Triamcinolone—ankylosing spondylitis	0.000224	0.00156	CcSEcCtD
Gadoxetate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000224	0.00156	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000224	0.00156	CcSEcCtD
Gadoxetate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000223	0.00155	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000223	0.00155	CcSEcCtD
Gadoxetate—Oedema—Prednisone—ankylosing spondylitis	0.000223	0.00155	CcSEcCtD
Gadoxetate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000223	0.00155	CcSEcCtD
Gadoxetate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000223	0.00155	CcSEcCtD
Gadoxetate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000223	0.00155	CcSEcCtD
Gadoxetate—Infection—Prednisone—ankylosing spondylitis	0.000221	0.00154	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000221	0.00154	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000221	0.00154	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—ankylosing spondylitis	0.000221	0.00154	CcSEcCtD
Gadoxetate—Fatigue—Betamethasone—ankylosing spondylitis	0.000221	0.00154	CcSEcCtD
Gadoxetate—Fatigue—Dexamethasone—ankylosing spondylitis	0.000221	0.00154	CcSEcCtD
Gadoxetate—Shock—Prednisone—ankylosing spondylitis	0.000219	0.00153	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000219	0.00152	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—ankylosing spondylitis	0.000218	0.00152	CcSEcCtD
Gadoxetate—Skin disorder—Prednisone—ankylosing spondylitis	0.000217	0.00151	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000216	0.0015	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—ankylosing spondylitis	0.000215	0.0015	CcSEcCtD
Gadoxetate—Anorexia—Prednisone—ankylosing spondylitis	0.000212	0.00148	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000212	0.00148	CcSEcCtD
Gadoxetate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000211	0.00147	CcSEcCtD
Gadoxetate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000211	0.00147	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000209	0.00146	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000209	0.00146	CcSEcCtD
Gadoxetate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000208	0.00145	CcSEcCtD
Gadoxetate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000207	0.00145	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—ankylosing spondylitis	0.000206	0.00144	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—ankylosing spondylitis	0.000205	0.00143	CcSEcCtD
Gadoxetate—Urticaria—Dexamethasone—ankylosing spondylitis	0.000203	0.00142	CcSEcCtD
Gadoxetate—Urticaria—Betamethasone—ankylosing spondylitis	0.000203	0.00142	CcSEcCtD
Gadoxetate—Dizziness—Prednisolone—ankylosing spondylitis	0.000203	0.00141	CcSEcCtD
Gadoxetate—Asthenia—Triamcinolone—ankylosing spondylitis	0.000202	0.00141	CcSEcCtD
Gadoxetate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000202	0.00141	CcSEcCtD
Gadoxetate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000202	0.00141	CcSEcCtD
Gadoxetate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000202	0.00141	CcSEcCtD
Gadoxetate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000202	0.00141	CcSEcCtD
Gadoxetate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000202	0.00141	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—ankylosing spondylitis	0.0002	0.0014	CcSEcCtD
Gadoxetate—Pruritus—Triamcinolone—ankylosing spondylitis	0.0002	0.00139	CcSEcCtD
Gadoxetate—Cough—Methotrexate—ankylosing spondylitis	0.000199	0.00139	CcSEcCtD
Gadoxetate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000199	0.00139	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—ankylosing spondylitis	0.000198	0.00138	CcSEcCtD
Gadoxetate—Chest pain—Methotrexate—ankylosing spondylitis	0.000194	0.00135	CcSEcCtD
Gadoxetate—Decreased appetite—Prednisone—ankylosing spondylitis	0.000194	0.00135	CcSEcCtD
Gadoxetate—Rash—Prednisolone—ankylosing spondylitis	0.000193	0.00135	CcSEcCtD
Gadoxetate—Dermatitis—Prednisolone—ankylosing spondylitis	0.000193	0.00135	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000193	0.00135	CcSEcCtD
Gadoxetate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000193	0.00134	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—ankylosing spondylitis	0.000192	0.00134	CcSEcCtD
Gadoxetate—Headache—Prednisolone—ankylosing spondylitis	0.000192	0.00134	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—ankylosing spondylitis	0.000192	0.00134	CcSEcCtD
Gadoxetate—Constipation—Prednisone—ankylosing spondylitis	0.000191	0.00133	CcSEcCtD
Gadoxetate—Dizziness—Triamcinolone—ankylosing spondylitis	0.000187	0.0013	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000186	0.0013	CcSEcCtD
Gadoxetate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000186	0.0013	CcSEcCtD
Gadoxetate—Infection—Methotrexate—ankylosing spondylitis	0.000185	0.00129	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000184	0.00128	CcSEcCtD
Gadoxetate—Asthenia—Betamethasone—ankylosing spondylitis	0.000184	0.00128	CcSEcCtD
Gadoxetate—Asthenia—Dexamethasone—ankylosing spondylitis	0.000184	0.00128	CcSEcCtD
Gadoxetate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000183	0.00127	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000182	0.00127	CcSEcCtD
Gadoxetate—Nausea—Prednisolone—ankylosing spondylitis	0.000182	0.00127	CcSEcCtD
Gadoxetate—Pruritus—Dexamethasone—ankylosing spondylitis	0.000181	0.00126	CcSEcCtD
Gadoxetate—Pruritus—Betamethasone—ankylosing spondylitis	0.000181	0.00126	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—ankylosing spondylitis	0.000181	0.00126	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00018	0.00126	CcSEcCtD
Gadoxetate—Vomiting—Triamcinolone—ankylosing spondylitis	0.000179	0.00125	CcSEcCtD
Gadoxetate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000179	0.00125	CcSEcCtD
Gadoxetate—Rash—Triamcinolone—ankylosing spondylitis	0.000178	0.00124	CcSEcCtD
Gadoxetate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000178	0.00124	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—ankylosing spondylitis	0.000178	0.00124	CcSEcCtD
Gadoxetate—Rash—Methylprednisolone—ankylosing spondylitis	0.000177	0.00124	CcSEcCtD
Gadoxetate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000177	0.00124	CcSEcCtD
Gadoxetate—Urticaria—Prednisone—ankylosing spondylitis	0.000177	0.00123	CcSEcCtD
Gadoxetate—Headache—Triamcinolone—ankylosing spondylitis	0.000177	0.00123	CcSEcCtD
Gadoxetate—Headache—Methylprednisolone—ankylosing spondylitis	0.000176	0.00123	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—ankylosing spondylitis	0.000176	0.00123	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—ankylosing spondylitis	0.000176	0.00123	CcSEcCtD
Gadoxetate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000175	0.00122	CcSEcCtD
Gadoxetate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000175	0.00122	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—ankylosing spondylitis	0.000174	0.00121	CcSEcCtD
Gadoxetate—Dizziness—Betamethasone—ankylosing spondylitis	0.000169	0.00118	CcSEcCtD
Gadoxetate—Dizziness—Dexamethasone—ankylosing spondylitis	0.000169	0.00118	CcSEcCtD
Gadoxetate—Nausea—Triamcinolone—ankylosing spondylitis	0.000168	0.00117	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000167	0.00117	CcSEcCtD
Gadoxetate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000167	0.00117	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000166	0.00116	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000164	0.00115	CcSEcCtD
Gadoxetate—Vomiting—Dexamethasone—ankylosing spondylitis	0.000163	0.00113	CcSEcCtD
Gadoxetate—Vomiting—Betamethasone—ankylosing spondylitis	0.000163	0.00113	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000162	0.00113	CcSEcCtD
Gadoxetate—Rash—Betamethasone—ankylosing spondylitis	0.000161	0.00113	CcSEcCtD
Gadoxetate—Rash—Dexamethasone—ankylosing spondylitis	0.000161	0.00113	CcSEcCtD
Gadoxetate—Dermatitis—Betamethasone—ankylosing spondylitis	0.000161	0.00112	CcSEcCtD
Gadoxetate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000161	0.00112	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000161	0.00112	CcSEcCtD
Gadoxetate—Fatigue—Methotrexate—ankylosing spondylitis	0.000161	0.00112	CcSEcCtD
Gadoxetate—Headache—Dexamethasone—ankylosing spondylitis	0.00016	0.00112	CcSEcCtD
Gadoxetate—Headache—Betamethasone—ankylosing spondylitis	0.00016	0.00112	CcSEcCtD
Gadoxetate—Asthenia—Prednisone—ankylosing spondylitis	0.00016	0.00112	CcSEcCtD
Gadoxetate—Pruritus—Prednisone—ankylosing spondylitis	0.000158	0.0011	CcSEcCtD
Gadoxetate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000154	0.00107	CcSEcCtD
Gadoxetate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000153	0.00106	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000152	0.00106	CcSEcCtD
Gadoxetate—Nausea—Betamethasone—ankylosing spondylitis	0.000152	0.00106	CcSEcCtD
Gadoxetate—Nausea—Dexamethasone—ankylosing spondylitis	0.000152	0.00106	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—ankylosing spondylitis	0.000148	0.00103	CcSEcCtD
Gadoxetate—Dizziness—Prednisone—ankylosing spondylitis	0.000147	0.00103	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000147	0.00103	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000147	0.00103	CcSEcCtD
Gadoxetate—Vomiting—Prednisone—ankylosing spondylitis	0.000142	0.000988	CcSEcCtD
Gadoxetate—Rash—Prednisone—ankylosing spondylitis	0.000141	0.00098	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—ankylosing spondylitis	0.00014	0.000979	CcSEcCtD
Gadoxetate—Headache—Prednisone—ankylosing spondylitis	0.00014	0.000974	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000137	0.000957	CcSEcCtD
Gadoxetate—Asthenia—Methotrexate—ankylosing spondylitis	0.000134	0.000932	CcSEcCtD
Gadoxetate—Nausea—Prednisone—ankylosing spondylitis	0.000132	0.000923	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—ankylosing spondylitis	0.000132	0.000919	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000127	0.000889	CcSEcCtD
Gadoxetate—Dizziness—Methotrexate—ankylosing spondylitis	0.000123	0.000859	CcSEcCtD
Gadoxetate—Vomiting—Methotrexate—ankylosing spondylitis	0.000118	0.000826	CcSEcCtD
Gadoxetate—Rash—Methotrexate—ankylosing spondylitis	0.000117	0.000819	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—ankylosing spondylitis	0.000117	0.000818	CcSEcCtD
Gadoxetate—Headache—Methotrexate—ankylosing spondylitis	0.000117	0.000814	CcSEcCtD
Gadoxetate—Nausea—Methotrexate—ankylosing spondylitis	0.000111	0.000772	CcSEcCtD
